nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0439	0.0574	CbGbCtD
Guanfacine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0413	0.054	CbGbCtD
Guanfacine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0374	0.0488	CbGbCtD
Guanfacine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0374	0.0488	CbGbCtD
Guanfacine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0365	0.0477	CbGbCtD
Guanfacine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0343	0.0449	CbGbCtD
Guanfacine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0343	0.0449	CbGbCtD
Guanfacine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0322	0.0421	CbGbCtD
Guanfacine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0313	0.0409	CbGbCtD
Guanfacine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0311	0.0406	CbGbCtD
Guanfacine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0311	0.0406	CbGbCtD
Guanfacine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0283	0.037	CbGbCtD
Guanfacine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0283	0.037	CbGbCtD
Guanfacine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0271	0.0355	CbGbCtD
Guanfacine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0268	0.035	CbGbCtD
Guanfacine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.026	0.034	CbGbCtD
Guanfacine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0235	0.0307	CbGbCtD
Guanfacine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0235	0.0307	CbGbCtD
Guanfacine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0226	0.0295	CbGbCtD
Guanfacine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0212	0.0277	CbGbCtD
Guanfacine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.02	0.0261	CbGbCtD
Guanfacine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.02	0.0261	CbGbCtD
Guanfacine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0181	0.0236	CbGbCtD
Guanfacine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0181	0.0236	CbGbCtD
Guanfacine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0156	0.0204	CbGbCtD
Guanfacine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0151	0.0198	CbGbCtD
Guanfacine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0137	0.0179	CbGbCtD
Guanfacine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0137	0.0179	CbGbCtD
Guanfacine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0131	0.0171	CbGbCtD
Guanfacine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00116	0.0841	CbGeAlD
Guanfacine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000895	0.0652	CbGeAlD
Guanfacine—NISCH—blood—acquired immunodeficiency syndrome	0.000872	0.0635	CbGeAlD
Guanfacine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000867	0.0632	CbGeAlD
Guanfacine—NISCH—bone marrow—acquired immunodeficiency syndrome	0.000844	0.0614	CbGeAlD
Guanfacine—NISCH—spinal cord—acquired immunodeficiency syndrome	0.00084	0.0612	CbGeAlD
Guanfacine—NISCH—vagina—acquired immunodeficiency syndrome	0.000808	0.0589	CbGeAlD
Guanfacine—NISCH—lung—acquired immunodeficiency syndrome	0.000764	0.0557	CbGeAlD
Guanfacine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000683	0.0497	CbGeAlD
Guanfacine—NISCH—brain—acquired immunodeficiency syndrome	0.000541	0.0394	CbGeAlD
Guanfacine—NISCH—lymph node—acquired immunodeficiency syndrome	0.000523	0.0381	CbGeAlD
Guanfacine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000444	0.0323	CbGeAlD
Guanfacine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000423	0.0308	CbGeAlD
Guanfacine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000392	0.0286	CbGeAlD
Guanfacine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000344	0.0251	CbGeAlD
Guanfacine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000328	0.0239	CbGeAlD
Guanfacine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000318	0.0231	CbGeAlD
Guanfacine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000306	0.0223	CbGeAlD
Guanfacine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000295	0.0215	CbGeAlD
Guanfacine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000279	0.0203	CbGeAlD
Guanfacine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000274	0.00124	CcSEcCtD
Guanfacine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000274	0.00124	CcSEcCtD
Guanfacine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000273	0.00124	CcSEcCtD
Guanfacine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000273	0.00124	CcSEcCtD
Guanfacine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000273	0.00124	CcSEcCtD
Guanfacine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00124	CcSEcCtD
Guanfacine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000272	0.00123	CcSEcCtD
Guanfacine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000272	0.00123	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000272	0.00123	CcSEcCtD
Guanfacine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000271	0.00123	CcSEcCtD
Guanfacine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00027	0.00123	CcSEcCtD
Guanfacine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.00123	CcSEcCtD
Guanfacine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00122	CcSEcCtD
Guanfacine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00027	0.00122	CcSEcCtD
Guanfacine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00027	0.00122	CcSEcCtD
Guanfacine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00122	CcSEcCtD
Guanfacine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000269	0.00122	CcSEcCtD
Guanfacine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000268	0.00122	CcSEcCtD
Guanfacine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000268	0.00121	CcSEcCtD
Guanfacine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000268	0.00121	CcSEcCtD
Guanfacine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000268	0.00121	CcSEcCtD
Guanfacine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000266	0.00121	CcSEcCtD
Guanfacine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000266	0.00121	CcSEcCtD
Guanfacine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000266	0.0012	CcSEcCtD
Guanfacine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000265	0.0012	CcSEcCtD
Guanfacine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000265	0.0012	CcSEcCtD
Guanfacine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000265	0.0012	CcSEcCtD
Guanfacine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000265	0.0012	CcSEcCtD
Guanfacine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000265	0.0012	CcSEcCtD
Guanfacine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000264	0.0012	CcSEcCtD
Guanfacine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000264	0.0012	CcSEcCtD
Guanfacine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000264	0.0012	CcSEcCtD
Guanfacine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000264	0.0012	CcSEcCtD
Guanfacine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.00119	CcSEcCtD
Guanfacine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000263	0.00119	CcSEcCtD
Guanfacine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000263	0.00119	CcSEcCtD
Guanfacine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000263	0.0191	CbGeAlD
Guanfacine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000262	0.00119	CcSEcCtD
Guanfacine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000262	0.00119	CcSEcCtD
Guanfacine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000262	0.00119	CcSEcCtD
Guanfacine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000261	0.00118	CcSEcCtD
Guanfacine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000261	0.00118	CcSEcCtD
Guanfacine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.00118	CcSEcCtD
Guanfacine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00026	0.00118	CcSEcCtD
Guanfacine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.00118	CcSEcCtD
Guanfacine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.00118	CcSEcCtD
Guanfacine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.00118	CcSEcCtD
Guanfacine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000259	0.00118	CcSEcCtD
Guanfacine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.00118	CcSEcCtD
Guanfacine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.00117	CcSEcCtD
Guanfacine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000258	0.0188	CbGeAlD
Guanfacine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000257	0.00117	CcSEcCtD
Guanfacine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000257	0.00117	CcSEcCtD
Guanfacine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.00117	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000257	0.00116	CcSEcCtD
Guanfacine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000255	0.00116	CcSEcCtD
Guanfacine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000255	0.00116	CcSEcCtD
Guanfacine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.00116	CcSEcCtD
Guanfacine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.00115	CcSEcCtD
Guanfacine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.00115	CcSEcCtD
Guanfacine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000254	0.00115	CcSEcCtD
Guanfacine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000253	0.00115	CcSEcCtD
Guanfacine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000253	0.00115	CcSEcCtD
Guanfacine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.00115	CcSEcCtD
Guanfacine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000253	0.00115	CcSEcCtD
Guanfacine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000253	0.00115	CcSEcCtD
Guanfacine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.00114	CcSEcCtD
Guanfacine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000252	0.00114	CcSEcCtD
Guanfacine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.00114	CcSEcCtD
Guanfacine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00114	CcSEcCtD
Guanfacine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000251	0.00114	CcSEcCtD
Guanfacine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000251	0.00114	CcSEcCtD
Guanfacine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00114	CcSEcCtD
Guanfacine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00114	CcSEcCtD
Guanfacine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00114	CcSEcCtD
Guanfacine—CYP3A4—blood—acquired immunodeficiency syndrome	0.00025	0.0182	CbGeAlD
Guanfacine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.00113	CcSEcCtD
Guanfacine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.00113	CcSEcCtD
Guanfacine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000249	0.00113	CcSEcCtD
Guanfacine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000248	0.0181	CbGeAlD
Guanfacine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000248	0.00113	CcSEcCtD
Guanfacine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.00112	CcSEcCtD
Guanfacine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000247	0.00112	CcSEcCtD
Guanfacine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00111	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000246	0.00111	CcSEcCtD
Guanfacine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.00111	CcSEcCtD
Guanfacine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000245	0.00111	CcSEcCtD
Guanfacine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.00111	CcSEcCtD
Guanfacine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000245	0.00111	CcSEcCtD
Guanfacine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000244	0.00111	CcSEcCtD
Guanfacine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000244	0.00111	CcSEcCtD
Guanfacine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000244	0.00111	CcSEcCtD
Guanfacine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000244	0.0011	CcSEcCtD
Guanfacine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.0011	CcSEcCtD
Guanfacine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000243	0.0011	CcSEcCtD
Guanfacine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000243	0.0011	CcSEcCtD
Guanfacine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000242	0.0011	CcSEcCtD
Guanfacine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.0011	CcSEcCtD
Guanfacine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.00109	CcSEcCtD
Guanfacine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000241	0.00109	CcSEcCtD
Guanfacine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000241	0.00109	CcSEcCtD
Guanfacine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000241	0.00109	CcSEcCtD
Guanfacine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000241	0.00109	CcSEcCtD
Guanfacine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000241	0.00109	CcSEcCtD
Guanfacine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.00109	CcSEcCtD
Guanfacine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00024	0.00109	CcSEcCtD
Guanfacine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00024	0.00109	CcSEcCtD
Guanfacine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.00108	CcSEcCtD
Guanfacine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.00108	CcSEcCtD
Guanfacine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.00108	CcSEcCtD
Guanfacine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.00108	CcSEcCtD
Guanfacine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000238	0.00108	CcSEcCtD
Guanfacine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.00107	CcSEcCtD
Guanfacine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.00107	CcSEcCtD
Guanfacine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000236	0.00107	CcSEcCtD
Guanfacine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000235	0.00107	CcSEcCtD
Guanfacine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000235	0.00106	CcSEcCtD
Guanfacine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.00106	CcSEcCtD
Guanfacine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.00106	CcSEcCtD
Guanfacine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000234	0.00106	CcSEcCtD
Guanfacine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000233	0.00106	CcSEcCtD
Guanfacine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.00106	CcSEcCtD
Guanfacine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000233	0.00106	CcSEcCtD
Guanfacine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000233	0.00105	CcSEcCtD
Guanfacine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000233	0.00105	CcSEcCtD
Guanfacine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00105	CcSEcCtD
Guanfacine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.00105	CcSEcCtD
Guanfacine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000232	0.00105	CcSEcCtD
Guanfacine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000231	0.00105	CcSEcCtD
Guanfacine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000231	0.00105	CcSEcCtD
Guanfacine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.00105	CcSEcCtD
Guanfacine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.00105	CcSEcCtD
Guanfacine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000231	0.00105	CcSEcCtD
Guanfacine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.00104	CcSEcCtD
Guanfacine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000229	0.00104	CcSEcCtD
Guanfacine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000229	0.00104	CcSEcCtD
Guanfacine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.00104	CcSEcCtD
Guanfacine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000228	0.00103	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.00103	CcSEcCtD
Guanfacine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000227	0.00103	CcSEcCtD
Guanfacine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000227	0.00103	CcSEcCtD
Guanfacine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.00102	CcSEcCtD
Guanfacine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.00102	CcSEcCtD
Guanfacine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.00102	CcSEcCtD
Guanfacine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.00102	CcSEcCtD
Guanfacine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.00101	CcSEcCtD
Guanfacine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.00101	CcSEcCtD
Guanfacine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00101	CcSEcCtD
Guanfacine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.00101	CcSEcCtD
Guanfacine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.001	CcSEcCtD
Guanfacine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000221	0.001	CcSEcCtD
Guanfacine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00022	0.000997	CcSEcCtD
Guanfacine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00022	0.000997	CcSEcCtD
Guanfacine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.000996	CcSEcCtD
Guanfacine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00022	0.000995	CcSEcCtD
Guanfacine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000219	0.000994	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000992	CcSEcCtD
Guanfacine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.000985	CcSEcCtD
Guanfacine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.000983	CcSEcCtD
Guanfacine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000216	0.000979	CcSEcCtD
Guanfacine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000978	CcSEcCtD
Guanfacine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.000975	CcSEcCtD
Guanfacine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000214	0.000971	CcSEcCtD
Guanfacine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.000971	CcSEcCtD
Guanfacine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.00097	CcSEcCtD
Guanfacine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000968	CcSEcCtD
Guanfacine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.000967	CcSEcCtD
Guanfacine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.000967	CcSEcCtD
Guanfacine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000212	0.000962	CcSEcCtD
Guanfacine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.000958	CcSEcCtD
Guanfacine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000957	CcSEcCtD
Guanfacine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.000946	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000946	CcSEcCtD
Guanfacine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000942	CcSEcCtD
Guanfacine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000939	CcSEcCtD
Guanfacine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000939	CcSEcCtD
Guanfacine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000933	CcSEcCtD
Guanfacine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000932	CcSEcCtD
Guanfacine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.000931	CcSEcCtD
Guanfacine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000926	CcSEcCtD
Guanfacine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000204	0.000926	CcSEcCtD
Guanfacine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.000925	CcSEcCtD
Guanfacine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000925	CcSEcCtD
Guanfacine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000923	CcSEcCtD
Guanfacine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000203	0.0148	CbGeAlD
Guanfacine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000202	0.000917	CcSEcCtD
Guanfacine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.000917	CcSEcCtD
Guanfacine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000202	0.000916	CcSEcCtD
Guanfacine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.000914	CcSEcCtD
Guanfacine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000201	0.000911	CcSEcCtD
Guanfacine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000904	CcSEcCtD
Guanfacine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000903	CcSEcCtD
Guanfacine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000901	CcSEcCtD
Guanfacine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000897	CcSEcCtD
Guanfacine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000895	CcSEcCtD
Guanfacine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000197	0.000895	CcSEcCtD
Guanfacine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000894	CcSEcCtD
Guanfacine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000197	0.0144	CbGeAlD
Guanfacine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.00089	CcSEcCtD
Guanfacine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000888	CcSEcCtD
Guanfacine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000196	0.0142	CbGeAlD
Guanfacine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.000878	CcSEcCtD
Guanfacine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000193	0.000875	CcSEcCtD
Guanfacine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000865	CcSEcCtD
Guanfacine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000191	0.000864	CcSEcCtD
Guanfacine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000191	0.0139	CbGeAlD
Guanfacine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000861	CcSEcCtD
Guanfacine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00019	0.00086	CcSEcCtD
Guanfacine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000856	CcSEcCtD
Guanfacine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000188	0.000853	CcSEcCtD
Guanfacine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000188	0.000852	CcSEcCtD
Guanfacine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000849	CcSEcCtD
Guanfacine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000187	0.000848	CcSEcCtD
Guanfacine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000186	0.000845	CcSEcCtD
Guanfacine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.000837	CcSEcCtD
Guanfacine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000833	CcSEcCtD
Guanfacine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000821	CcSEcCtD
Guanfacine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.000813	CcSEcCtD
Guanfacine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000812	CcSEcCtD
Guanfacine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.000809	CcSEcCtD
Guanfacine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.000806	CcSEcCtD
Guanfacine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.000805	CcSEcCtD
Guanfacine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000804	CcSEcCtD
Guanfacine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000802	CcSEcCtD
Guanfacine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.000801	CcSEcCtD
Guanfacine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.0008	CcSEcCtD
Guanfacine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000781	CcSEcCtD
Guanfacine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000778	CcSEcCtD
Guanfacine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000774	CcSEcCtD
Guanfacine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.000771	CcSEcCtD
Guanfacine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.00077	CcSEcCtD
Guanfacine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.00077	CcSEcCtD
Guanfacine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.000766	CcSEcCtD
Guanfacine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000765	CcSEcCtD
Guanfacine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.000759	CcSEcCtD
Guanfacine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000748	CcSEcCtD
Guanfacine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000745	CcSEcCtD
Guanfacine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000745	CcSEcCtD
Guanfacine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000735	CcSEcCtD
Guanfacine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000726	CcSEcCtD
Guanfacine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.00072	CcSEcCtD
Guanfacine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000719	CcSEcCtD
Guanfacine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000713	CcSEcCtD
Guanfacine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000712	CcSEcCtD
Guanfacine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000711	CcSEcCtD
Guanfacine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000709	CcSEcCtD
Guanfacine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000692	CcSEcCtD
Guanfacine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000687	CcSEcCtD
Guanfacine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000686	CcSEcCtD
Guanfacine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000686	CcSEcCtD
Guanfacine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000682	CcSEcCtD
Guanfacine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000672	CcSEcCtD
Guanfacine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.00066	CcSEcCtD
Guanfacine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000655	CcSEcCtD
Guanfacine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000654	CcSEcCtD
Guanfacine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000651	CcSEcCtD
Guanfacine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000647	CcSEcCtD
Guanfacine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000617	CcSEcCtD
